Intervention Protocol

Botulinum toxin type A formulations in focal dystonias

  1. João Costa*,
  2. Joaquim Ferreira,
  3. Rita Freire,
  4. Miguel M Coelho,
  5. Cristina Sampaio

Editorial Group: Cochrane Movement Disorders Group

Published Online: 26 JAN 2004

DOI: 10.1002/14651858.CD004313.pub2


How to Cite

Costa J, Ferreira J, Freire R, Coelho MM, Sampaio C. Botulinum toxin type A formulations in focal dystonias (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004313. DOI: 10.1002/14651858.CD004313.pub2.

Author Information

  1. Faculdade de Medicina de Lisboa, Laboratório de Farmacologia Clínica e Terapêutica, Lisboa, Portugal

*João Costa, Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Av. Prof. Egas Moniz, Lisboa, 1649-028, Portugal. joaoncosta@sapo.pt.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 JAN 2004

SEARCH

  1. Current Version

    Botulinum toxin type A formulations in focal dystonias

    João Costa, Joaquim Ferreira, Rita Freire, Miguel M Coelho and Cristina Sampaio

    Version of Record online: 26 JAN 2004 | DOI: 10.1002/14651858.CD004313.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Clinical comparability of botulinum toxin type A formulations in focal dystonias

    J Costa, JJ Ferreira, R Freire, M Coelho and C Sampaio

    Version of Record online: 6 MAY 2003 | DOI: 10.1002/14651858.CD004313